#PrecisionImmunotherapy
#SingleCellRNAsequencing is reshaping #leukemia research.
This review reveals how T-cell exhaustion and immunosuppressive networks drive disease progression, uncovering new targets for #PrecisionImmunotherapy.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
November 16, 2026 at 10:30 AM
#PrecisionImmunotherapy starts with precision biology.
This review shows how tumour genomics and immune profiling can guide biomarker-driven immunotherapy combinations to improve outcomes in #NSCLC. #Oncogenic
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
November 7, 2026 at 10:30 PM
🔬 NEW: CAR T cells engineered to target mutant calreticulin successfully depleted disease-driving cells in myelofibrosis mod…

#Calreticulinmutation #CARTcelltherapy #Myelofibrosis #Precisionimmunotherapy #Translationalresearch

#Calreticulinmutation #CARTcelltherapy #Myelofibrosis #Precisionimmu…
CAR T therapy targets myelofibrosis mutations
🔬 NEW: CAR T cells engineered to target mutant calreticulin successfully depleted disease-driving cells in myelofibrosis mod… #Calreticulinmutation #CARTcelltherapy #Myelofibrosis #Precisionimmunotherapy #Translationalresearch
news.gmj.ge
September 22, 2026 at 7:26 AM
Targeting autoreactive TRBV9+ T cells using TRBV9xCD3 bispecific T cell engaging antibodies. Controlling ankylosing spondylitis and celiac disease without increasing the risk of infection? Let's go. Join us at Room 150, 3:00 PM. #precisionimmunotherapy #ACR24
November 17, 2024 at 7:16 PM
And now a dive into the challenge of high resolution single tracking of immune killer cells in complex tumor environments with Gebhard Stopper.

#CBIAS2024 #PrecisionImmunoTherapy #cancer #super_resolution
November 26, 2024 at 10:06 AM